TrialCancer research and treatment2017

Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer.

Miso Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.